The value of multimodal magnetic resonance imaging in transcranial magnetic stimulation treatment of autism

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047950

Enrollment

Unknown

Registered

2021-06-28

Start date

2021-06-30

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism

Interventions

Experimental group:Transcranial Magnetic Stimulation

Eligibility

Sex/Gender

All

Age

5 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Chinese patients (no gender limit) aged >=5 years, with written informed consent provided by their guardians prior to any research-related procedures. 2. A patient with autism confirmed by a neurologist based on clinical history and examination. 3. Patients without contraindications for MRI scan and transcranial magnetic therapy.

Exclusion criteria

Exclusion criteria: 1. Those with other mental disorders, such as schizophrenia. 2. Have a serious neurological disease, such as a brain tumor or an intracranial infection. 3. Subjects whose weight exceeds the upper limit of the treatment bed or subjects who are not suitable for MRI scanning. 4. A history of seizures, genetic disorders, or brain abnormalities.

Design outcomes

Primary

Measure	Time frame
Functional rating scale;Functional magnetic resonance imaging;	—

Countries

China

Contacts

Public ContactWang Meiyun

He'nan Provincial People's Hospital

mywang@ha.edu.cn+86 15038165579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026